Bimekizumab Efficacy and Safety Over 48 Weeks in US and Canadian Patients with Psoriasis who had a Treatment Interruption After 3 Years of Treatment: Results from BE RADIANT. J of Skin [Internet]. 2024 Nov. 18 [cited 2025 Jul. 3];8(6):s431. Available from: https://skin.dermsquared.com/skin/article/view/3043